Delivery Order SPE2DR25D3304-SPE2DR26F47P5
- Not listed
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $2,252.25 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on September 18, 2025, with completion targeted for September 19, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract specifies performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,387.02 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price, non-set-aside contract will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $23,260.35 delivery order on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This is a firm fixed-price, non-set-aside contract with performance through November 5, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,523.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,867.47 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a completion deadline of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,945.20 delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled for completion by July 10, 2025, with performance occurring at...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F47P5Delivery Order
The Defense Logistics Agency awarded a $5,579.73 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the vendor's corporate headquarters location in Conshohocken, Pennsylvania, with a completion date of November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive DLA framework contract. The company's expansive pharmaceutical portfolio supports military and veteran healthcare systems with brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Trulicity, a diabetes management medication, exemplifies the company's role in supplying essential pharmaceuticals to support Defense Health Agency and other federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/14/25 |